LLY · Eli Lilly & Co.

LLY Eli Lilly & Co.

Healthcare & Biotech · Healthcare · ← Healthcare & Biotech Index

Gesamt ×462RS-Rating 71vom Hoch -3%Ø $-Vol 3177MMax-Runup ×589Max-DD -75%ADR 3.1%Score 2273Setups 10Rallyes 8Earnings 23Surf 100%🏄 10/20-Surfer

▲ im Chart anklicken → springt zur Zeile

Grade	Base-Start	Breakout	Tage	Tiefe%	Vorlauf%	Δ Tag%	Gap%	Vol×	Dry-Up%	ADR%	ext10%	Surf%	Setup	Formation	Katalysator
C	1987-08-17	1987-09-11	18	12.2	+24	+10.7	5.6	4.0	4	2.1	8	40	Episodic Pivot (Gap)	—	—:
C	2000-06-21	2000-06-29	6	6.2	+50	+16.5	17.0	6.2	-10	3.4	16	100	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2020-04-24	2020-06-16	36	14.9	+41	+15.7	10.5	3.6	28	3.0	10	40	Episodic Pivot (Gap)	Flat Base	—:
C	2020-12-17	2021-01-11	15	7.0	+35	+11.7	11.2	3.3	35	2.3	10	100	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2021-03-12	2021-06-07	59	14.3	+33	+10.1	-0.0	6.0	21	2.5	10	40	Base-Breakout	Flat Base	—:
C	2021-06-10	2021-06-24	10	8.0	+33	+7.3	8.2	2.9	6	2.9	4	100	Episodic Pivot (Gap)	Flag / Pennant	—:
C	2021-11-19	2021-12-15	17	11.6	+23	+10.4	5.1	3.1	-24	2.6	11	40	Episodic Pivot (Gap)	VCP (Contraction)	Earnings: Earnings-Report (SEC 8-K 2.02) ↗
C	2022-07-15	2022-09-28	52	11.6	+22	+7.5	7.2	3.3	12	2.6	8	40	Episodic Pivot (Gap)	Flat Base	News: LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data ↗
C	2023-06-30	2023-08-08	26	7.6	+34	+14.9	11.4	6.5	23	1.9	13	40	Episodic Pivot (Gap)	VCP (Contraction)	Earnings: Earnings-Report (SEC 8-K 2.02) ↗
C	2025-07-28	2025-10-01	46	23.9	+16	+8.2	0.0	2.9	-34	2.6	10	40	Breakout	VCP (Contraction)	News: CRISPR Therapies Clinical Trial Pipeline Shows Potential with Active Contributions from 25 ↗

Breakouts 10Trefferquote 50%Ø gehalten +4.8%Median +5.4%Ø Peak +16%Ø hergegeben −11%

Breakout	G	Entry	gehalten	Peak	hergeg.	Tage	Exit
1987-09-11	C	9.02	-7.6%	+4.8%	−12.4%	6	1987-09-21
2000-06-29	C	62.77	-14.1%	+21.9%	−35.9%	28	2000-08-09
2020-06-16	C	158	-1.6%	+4.0%	−5.6%	26	2020-07-23
2021-01-11	C	169	+16.6%	+25.4%	−8.7%	35	2021-03-03
2021-06-07	C	203	+25.6%	+33.4%	−7.8%	58	2021-08-27
2021-06-24	C	231	+10.5%	+17.3%	−6.9%	45	2021-08-27
2021-12-15	C	267	-1.5%	+4.8%	−6.3%	13	2022-01-04
2022-09-28	C	333	+5.4%	+10.6%	−5.2%	32	2022-11-11
2023-08-08	C	470	+17.1%	+28.1%	−11.0%	31	2023-09-21
2025-10-01	C	820	-2.1%	+5.4%	−7.5%	12	2025-10-17

Regel: Einstieg am Breakout-Pivot, Trailing-Stop = Tagesschluss unter dem 20-EMA. gehalten = realisierter Gewinn bis zum Stop · Peak = max. Run-Up (MFE) · hergeg. = Peak − gehalten · „offen" = Position läuft noch.

Jahr	Rendite	Spanne	Max-DD	Setups	Schluss
1982	+3%	44%	-28%		2.52
1983	+1%	21%	-17%		2.54
1984	+14%	27%	-18%		2.89
1985	+69%	74%	-9%		4.89
1986	+33%	66%	-22%		6.51
1987	+5%	87%	-41%	1	6.84
1988	+10%	29%	-16%		7.50
1989	+60%	62%	-9%		12.02
1990	+7%	54%	-26%		12.85
1991	+14%	26%	-16%		14.65
1992	-27%	52%	-32%		10.66
1993	-2%	42%	-29%		10.42
1994	+10%	41%	-23%		11.51
1995	+71%	82%	-10%		19.73
1996	+30%	63%	-19%		25.62
1997	+91%	98%	-17%		48.86
1998	+28%	58%	-19%		62.37
1999	-25%	61%	-37%		46.67
2000	+40%	102%	-38%	1	65.31
2001	-16%	36%	-21%		55.12
2002	-19%	85%	-40%		44.80
2003	+11%	40%	-21%		49.89
2004	-19%	53%	-34%		40.25
2005	+0%	23%	-18%		40.14
2006	-8%	18%	-14%		36.95
2007	+2%	24%	-19%		37.87
2008	-25%	101%	-48%		28.56
2009	-11%	50%	-32%		25.33
2010	-2%	19%	-14%		24.85
2011	+25%	30%	-12%		31.11
2012	+24%	44%	-14%		38.65
2013	+7%	21%	-17%		41.47
2014	+40%	54%	-7%		57.96
2015	+25%	38%	-14%		72.67
2016	-10%	30%	-20%		65.14
2017	+18%	24%	-10%		76.75
2018	+40%	67%	-15%		108
2019	+16%	36%	-18%		125
2020	+31%	51%	-22%	1	164
2021	+66%	78%	-19%	4	272
2022	+34%	63%	-13%	1	366
2023	+59%	109%	-15%	1	583
2024	+32%	68%	-24%		772
2025	+39%	78%	-33%	1	1075
2026	+5%	37%	-23%		1131

▲ 2009-03-05 → 2024-08-30 +4826% (3899 HT)

Auslöser: Earnings: Earnings-Report (SEC 8-K 2.02)

2021-12-15 +10% [Earnings] Earnings-Report (SEC 8-K 2.02)
2022-09-28 +7% [News] LLY & PRTA in Spotlight on BIIB-Eisai's AD Drug Data
2023-08-08 +15% [Earnings] Earnings-Report (SEC 8-K 2.02)
2024-08-08 +9% [Earnings] Earnings-Report (SEC 8-K 2.02)

▲ 1993-08-13 → 1999-03-05 +794% (1403 HT)